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ABSTRACT
Ultrasound (US) role is becoming 
more and more relevant in the assess-
ment of rheumatic diseases but there 
are still some almost unexplored fi elds 
and, surely, one of these is represented 
by the great family of connective tis-
sue diseases (CTD). In this review we 
provide an update of the available data 
regarding some applications of US in 
CTD. Besides an overview of the role 
of US in their musculoskeletal involve-
ment, we will report data on the use of 
US in the evaluation of skin and lung 
in systemic sclerosis and of salivary 
glands in Sjögren’s syndrome. US as-
sessment of heart, kidney or vascular 
involvement in CTD will not be the 
subjects of this paper.
Introduction
Several papers describe the clinical ap-
plications and fi ndings of musculoskel-
etal ultrasound (US) (1-8) in patients 
with arthritides, predominantly rheu-
matoid arthritis (9) but also spondy-
loarthritis (10), osteoarthritis (11) and 
crystal-related arthritis (12). US has 
also been successfully applied to im-
age multisystem involvement (heart, 
kidney and vessels) typical of connec-
tive tissue disorders (CTD) such as 
systemic lupus erythematosus (SLE), 
Sjögren’s syndrome (SS), systemic 
sclerosis (SSc), polymyositis (PM), 
dermatomyositis (DM), mixed connec-
tive tissue disease (MCTD) and undif-
ferentiated connective tissue disease 
(UCTD). To date, very few studies are 
reported in the literature about the ap-
plications of US in the assessment of 
joint and tendon involvement in the 
course of CTD.
In this review we provide an update of 
the available data regarding some ap-
plications of US in CTD. Besides an 
overview of the role of US in muscu-
loskeletal involvement in CTD we will 
report data on the use of US in the eval-
uation of skin and lung in SSc and of 
salivary glands in SS. US assessment 
of heart, kidney or vascular involve-
ment in CTD will not be the subjects 
of this paper.
Systemic lupus erythematosus
Joint involvement in SLE patients is 
very frequent, particularly at the wrists 
and hands. It may range from mild ar-
thralgia to severe non erosive deform-
ing arthritis (Jaccoud’s arthropathy), 
erosive arthritis resembling rheumatoid 
arthritis or mild deforming arthropathy 
(13). To the best of our knowledge, 
only two papers on SLE joint involve-
ment evaluated by musculoskeletal US 
are reported in literature. In 2004, Iag-
nocco et al. examined 52 wrists of 26 
SLE patients and demonstrated syno-
vitis in 22/52 radio-ulno-carpal joints 
with synovial proliferation in 10 joints, 
effusion in 13, power Doppler signal in 
5 and bone erosions in both wrists of 
the same patient (14). More recently, an 
ultrasound pictorial assay on hand and 
wrist arthritis in SLE showed joint ef-
fusion or synovial proliferation in 16 of 
17 patients at the wrist and at the meta-
carpo-phalangeal joints (MCP) in 12, 
bone erosions of the 2nd and 3rd MCP 
joints in 8 subjects and fi nger fl exor 
tenosynovitis in 11 patients (15). An 
interesting application of US coupled 
with color and power Doppler has been 
reported in 22 patients affected by SLE 
which showed hemodynamic changes 
in blood fl ow to the proximal femur 
even in the absence of osteonecrosis. 
The Authors suggest color Doppler 
evaluation of femoral head perfusion 
as a predictive test for hemodynamic 
deterioration (16). 
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Systemic sclerosis
Several features of SSc can be as-
sessed using US including joint and 
tendon involvement, the presence of 
subcutaneous calcifi cation and the 
skin features. To date only one study 
has investigated the role of US in the 
evaluation of SSc joints showing, at 
the distal phalanx of the hand, that the 
most frequent fi ndings are soft tissue 
calcifi cations and narrowing of the 
distance between phalangeal apex and 
skin surface (17). No US studies have 
been published on tendon involvement 
in SSc. Subcutaneous calcifi cation, 
even when incipient, can be imaged, 
using US, particularly over the palmar 
aspect of the fi nger (18). Dermatologi-
cal US was initiated in 1979 by Alex-
ander and Miller who measured skin 
thickness by a 15 MHz US (19). The 
development of very high frequency 
probes (20 MHz or more), which are 
mandatory to clearly distinguish epi-
dermidis, dermis and subcutaneous fat, 
has allowed not only the determination 
of thickness but also a qualitative as-
sessment of the skin. Thus, in recent 
times, several papers have reported the 
sonographic skin fi ndings in diffuse or 
localized scleroderma (20-24). How-
ever, lack of homogeneity among the 
different studies exists: fi rstly, the fre-
quency of the probes used ranged from 
10 to 32 MHz and, in addition, incon-
sistencies relating to the skin depth ex-
amined. In 2003, a longitudinal study 
(using a 20 MHz ultrasound probe) in 
16 patients (8 with diffuse and 8 with 
limited SSc) showed thickening and 
decreased echogenicity of the dermis 
in sclerotic skin in the early phases of 
the diseases. The degree of thicken-
ing tended to diminish with time and, 
at 4 years of disease duration, thick-
ness was signifi cantly decreased in the 
forearm and chest and echogenicity 
increased at the hands. The Authors 
concluded that US appeared as a good 
non-invasive tool to monitor disease 
progression (25). 
A 17-point dermal US scoring method 
has been proposed (using a 22 MHz 
US probe) based on the measurement 
of dermal thickness at 17 sites, corre-
sponding to those of the modifi ed Rod-
nan skin score. This scoring system 
may be a useful measure of outcome in 
the future (26). 
In SSc patients with short disease dura-
tion, US has been shown to be able to 
detect the oedematous phase that may 
precede palpable skin involvement, 
that could be useful in identifying 
patients with diffuse skin involvement 
in a very early disease phase (27).
Recently quantitative US has shown a 
decrease in the skin thickness after pho-
tochemotherapy in SSc (28). The appli-
cation of US in the evaluation of lung 
fi brosis in SSc patients is under investi-
gation. It would appear that both pleural 
effusion and interstitial change can be 
identifi ed using US and has been pro-
posed as a possible alternative to high 
resolution computed tomography in the 
follow-up of such patients (29, 30). 
Sjögren’s syndrome
Joint involvement is not rare in SS (31) 
and US can be useful in its evaluation 
and also to investigate changes in sali-
vary gland architecture. Iagnocco et al. 
studied knee involvement in patients 
with primary and secondary SS (associ-
ated with rheumatoid arthritis or CTD). 
They demonstrated mild synovitis in 
primary SS while joint effusion was 
more frequently present in secondary 
SS with rheumatoid arthritis (32). Sev-
eral studies based on the US fi ndings in 
the parotid and submandibular glands 
in primary SS have been published (33-
37). US examination of the salivary 
glands is performed using a 5-14 MHz 
linear transducer to assess the following 
parameters: parenchymal echogenicity, 
homogeneity, the presence of hypoe-
chogenic areas, hyperechogenic lines 
and/or dots, clarity of the glandular 
boundaries (see Table I). A reproducible 
scoring system (range 0 to 3) has been 
proposed by Hocevar et al. (38, 39) and 
by Wernicke et al. (range 0 to 2) (40). 
A further scoring system comparing US 
fi ndings with minor salivary gland bi-
opsy, proposed a US score (range 0 to 
4) which assigned points to the differ-
ent degrees of glandular inhomogenei-
ty (41). Recently, Shimizu et al. tried to 
precisely defi ne what “inhomogeneity” 
Table I. The US features which can be 
assessed in the salivary glands.
•  Parenchymal echogenicity
•  Homogeneity 
•  Presence of hypoechogenic areas
•  Hyperechogenic lines and/or dots
•  Clarity of glandular boundaries
Fig 1. Systemic sclerosis. Dorsal longitudinal (A) and transverse (B) views of the 3rd fi nger. The as-
terisk indicates hypoechoic thickening of the derma due to edema. mp = middle phalanx. Images taken 
using a MyLab70 XVG (Esaote Biomedica, Genoa – Italy) equipped with a 6-18 MHz linear probe. 
Volar longitudinal views of the right (C) and left (D) 2nd fi nger with right distal phalanx bone re-
sorption. The arrow indicates distal phalanx edge. dp = distal phalanx. Images taken using a Logiq 9 
(General Electrics, Milwakee – USA) equipped with a 15 MHz linear probe. 
For further ultrasound images, go to www.clinexprheumatol.org/ultrasound
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means and suggested a further grad-
ing (positive, probable and negative) 
(42). In comparison to other imaging 
tools, such as sialography, scintigraphy 
and MRI, US emerges as a very useful 
method for the diagnosis and follow-
up of salivary gland involvement in SS 
patients (43-45). Color Doppler sonog-
raphy has investigated blood fl ow be-
fore and after secretory stimulation and 
shows that blood fl ow response may be 
defective in the salivary glands of these 
patients (46).
Changes within the lacrimal glands 
in SS have been studied and demon-
strated signifi cant differences in size 
compared to normal subjects together 
with changes in echostructure due to 
fatty infi ltration or the presence of lym-
phoma. US was not able to accurately 
image atrophic glands due to their size 
and their isoechoic pattern indiscern-
ible from orbital fatty tissue (47). 
Polymyositis and dermatomyositis
Very few studies are reported on the role 
of musculoskeletal US in PM and DM. 
However, using a 7-9 MHz linear trans-
ducer array it is possible to evaluate 
muscle changes in myositis. With nor-
mal muscle bulk, fascicles appear ane-
choic or hypoechoic relative to septae. 
An isoechoic appearance is considered 
extremely abnormal, refl ecting dimin-
ished fascical size and closer space be-
tween fi brous septae.  Reimers et al. (48) 
reported muscle atrophy and increased 
echogenicity in the upper and lower 
limbs both in childhood and adult PM 
and DM. Higher echogenicity and more 
pronounced atrophy was usually present 
in chronic myositis, lower echogenic-
ity and muscle edema in acute myosi-
tis (48). In another study in 37 patients 
with DM or PM, the gray-scale evalua-
tion of muscle was correlated with pow-
er Doppler. Disease of longer duration 
was signifi cantly associated with more 
abnormal features on gray-scale exami-
nation, whilst power Doppler signal was 
increased in disease of shorter duration 
(49). Recently using contrast-enhanced 
US, muscle perfusion was studied in 35 
patients suspected of having PM and 
DM. In all patients, blood fl ow, vol-
ume and fl ow velocity were measured 
and compared to the results of MRI and 
muscle biopsy. Eleven out of 35 patients 
had histologically confi rmed DM or PM 
and signifi cantly higher perfusion pa-
rameters. The Authors concluded that 
contrast-enhanced US could be an ad-
ditional parameter for the diagnosis of 
infl ammatory myopathy (50). US can 
also be useful to aid needle positioning 
during muscle biopsy, however, MRI is 
still considered more sensitive than US 
in the detection of muscle edema. Cal-
cifi cation can easily be detected because 
of high echointensity and acoustic shad-
owing on US images (48).
Undifferentiated and mixed 
connective tissue disease
Very recently, a study on 14 UCTD 
patients suggested that power Doppler 
US has better accuracy than nailfold 
capillaroscopy in differentiating pri-
mary from secondary Raynaud’s phe-
nomenon and in assessing microvascu-
lar abnormalities (51).
Research agenda
Future areas for researchers to target in 
this fi eld include: 
- Defi nition of the features of the ar-
ticular and periarticular involvement 
in all CTD.
- Standardization of the scanning pro-
tocol of the skin.
- Study of the features of skin involve-
ment in SSc and MCTD.
- Evaluation of diagnostic accuracy and 
follow-up of skin US. 
- Study of muscle involvement not only 
in PM and DM but also in myositis 
associated with SLE and SSc using 
US and power Doppler examination. 
- Development of largely accepted crite-
ria to diagnose SS even in the absence 
of minor salivary glands biopsy.
- Role of US in the therapy monitor-
ing of the different manifestations of 
CTD.
Link
For further ultrasound images, go to 
www.clinexprheumatol.org/ultrasound
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